Collecting biomedical and social data in a longitudinal survey: A comparison of two approaches

The inclusion of the collection of biomeasures within social surveys, and longitudinal surveys in particular, is becoming ever more common. Combining objective measurements of health with detailed information about lifestyles and behaviour collected over long periods of time offers enormous research potential. Studies that combine an interview with the collection of biomeasures can be conducted in various ways. One model is that field interviewers make initial contact with participants, conduct the interviews and arrange follow-up visits for a nurse to collect the biomeasures. Alternatively, field interviewers can be trained to collect biomeasures, but there remain questions about whether the quality of data collected is comparable to that collected by a nurse. Other studies invite participants to visit clinics, but this can be very costly in a large-scale national study. There is no consensus on the optimal strategy for combining a social survey with the collection of biomeasures. The 1970 British Cohort Study (BCS70) is a longitudinal birth cohort study which began in 1970. The 11th sweep of the study began in 2016, when study members were aged 46, and included an interview component alongside the collection of a range of biomeasures. The first phase of fieldwork was conducted using a new approach where nurses conducted all of the data collection. Midway through fieldwork BCS70 switched to a two-stage approach where interviews were conducted by interviewers followed by a separate nurse visit. This presented a unique opportunity to evaluate the success of the two approaches

State Legislative Update

Effective July 1, 1995, as part of the nursing facility enforcement regulations, the Centers for Medicare & Medicaid Services required states to provide nursing facilities with the opportunity for informal dispute reolution reviews. This dispute resolution system was set up in order to avoid the potentially prolonged resolution process associated with more formal appeals. These regulations do not prevent a nursing facility from pursuing a former appeal of the disputed deficiency, but the regulations do give an expedited alternative to the formal process

State Legislative Update

Effective July 1, 1995, as part of the nursing facility enforcement regulations, the Centers for Medicare & Medicaid Services required states to provide nursing facilities with the opportunity for informal dispute reolution reviews. This dispute resolution system was set up in order to avoid the potentially prolonged resolution process associated with more formal appeals. These regulations do not prevent a nursing facility from pursuing a former appeal of the disputed deficiency, but the regulations do give an expedited alternative to the formal process

Catalyzing Rebellion: An Introduction to the Mobilization in Miniature Project

http://deepblue.lib.umich.edu/bitstream/2027.42/50913/1/138.pd

Rapid Global Expansion of the Fungal Disease Chytridiomycosis into Declining and Healthy Amphibian Populations

Published versio

Association between HbA1c and the development of cystic fibrosis‐related diabetes

Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related diabetes and to assess the association with the development of retinopathy in people with cystic fibrosis‐related diabetes. Methods A 7‐year retrospective longitudinal study was conducted in 50 adults with cystic fibrosis, comparing oral glucose tolerance test results with HbA1c values in predicting the development of cystic fibrosis‐related diabetes. Retinal screening data were also compared with HbA1c measurements to assess microvascular outcome. Results An HbA1c value ≥37 mmol/mol (5.5%; hazard ratio 3.49, CI 1.5–8.1) was significantly associated with the development of dysglycaemia, as defined by the oral glucose tolerance test over a 7‐year period. Severity of diabetic retinopathy was associated with a higher HbA1c and longer duration of cystic fibrosis‐related diabetes. Conclusion There is a link between HbA1c level and the future development of dysglycaemia in cystic fibrosis based on oral glucose tolerance test, as well as microvascular outcomes. Although current guidance does not advocate the use of HbA1c as a diagnostic tool in cystic fibrosis‐related diabetes, it may be of clinical use in determining individuals at risk of future development of cystic fibrosis‐related diabetes

Revised CRISM spectral parameters and summary products based on the currently detected mineral diversity on Mars

The investigation of hyperspectral data from the Mars Reconnaissance Orbiter Compact Reconnaissance Imaging Spectrometer for Mars (CRISM) and the Observatoire pour la Minéralogie, L'Eau, les Glaces et l'Activitié (OMEGA) on Mars Express has revealed an increasingly diverse suite of minerals present on the Martian surface. A revised set of 60 spectral parameters derived from corrected spectral reflectance at key wavelengths in CRISM targeted observations and designed to capture the known diversity of surface mineralogy on Mars is presented here as “summary products.” Some of the summary products have strong heritage to OMEGA spectral parameter calculations; this paper also presents newly derived parameters that highlight locations with more recently discovered spectral signatures. Type locations for the diversity of currently identified mineral spectral signatures have been compiled into a library presented in this work. Our analysis indicates that the revised set of summary products captures the known spectral diversity of the surface, and successfully highlights and differentiates between locations with differing spectral signatures. The revised spectral parameter calculations and related products provide a useful tool for scientific interpretation and for future mission landing site selection and operations

Uncoupling reproduction from metabolism extends chronological lifespan in yeast

Studies of replicative and chronological lifespan in Saccharomyces cerevisiae have advanced understanding of longevity in all eukaryotes. Chronological lifespan in this species is defined as the agedependent viability of nondividing cells. To date this parameter has only been estimated under calorie restriction, mimicked by starvation. Because postmitotic cells in higher eukaryotes often do not starve, we developed a model yeast system to study cells as they age in the absence of calorie restriction. Yeast cells were encapsulated in a matrix consisting of calcium alginate to form ~3 mm beads that were packed into bioreactors and fed ad libitum. Under these conditions cells ceased to divide, became heat shock and zymolyase resistant, yet retained high fermentative capacity. Over the course of 17 d, immobilized yeast cells maintained 10%. Immobilized cells exhibited a stable pattern of gene expression that differed markedly from growing or starving planktonic cells, highly expressing genes in glycolysis, cell wall remodeling, and stress resistance, but decreasing transcription of genes in the tricarboxylic acid cycle, and genes that regulate the cell cycle, including master cyclins CDC28 and CLN1. Stress resistance transcription factor MSN4 and its upstream effector RIM15 are conspicuously up-regulated in the immobilized state, and an immobilized rim15 knockout strain fails to exhibit the long-lived, growth-Arrested phenotype, suggesting that altered regulation of the Rim15-mediated nutrient-sensing pathway plays an important role in extending yeast chronological lifespan under calorie-unrestricted conditions

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence

<p>Abstract</p> <p>Background</p> <p>Anti-Aβ immunotherapy is a promising approach to the prevention and treatment of Alzheimer's disease (AD) currently in clinical trials. There is extensive evidence, both in mice and humans that a significant adverse event is the occurrence of microhemorrhages. Also, vasogenic edema was reported in phase 2 of a passive immunization clinical trial. In order to overcome these vascular adverse effects it is critical that we understand the mechanism(s) by which they occur.</p> <p>Methods</p> <p>We have examined the matrix metalloproteinase (MMP) protein degradation system in two previously published anti-Aβ immunotherapy studies. The first was a passive immunization study in which we examined 22 month old APPSw mice that had received anti-Aβ antibodies for 1, 2 or 3 months. The second is an active vaccination study in which we examined 16 month old APPSw/NOS2-/- mice treated with Aβ vaccination for 4 months.</p> <p>Results</p> <p>There is a significant activation of the MMP2 and MMP9 proteinase degradation systems by anti-Aβ immunotherapy, regardless of whether this is delivered through active vaccination or passive immunization. We have characterized this activation by gene expression, protein expression and zymography assessment of MMP activity.</p> <p>Conclusions</p> <p>Since the MMP2 and MMP9 systems are heavily implicated in the pathophysiology of intracerbral hemorrhage, these data may provide a potential mechanism of microhemorrhage due to immunotherapy. Increased activity of the MMP system, therefore, is likely to be a major factor in increased microhemorrhage occurrence.</p